/Investor DB

Iaso Ventures — Full Portfolio

32 tracked investments · listed companies and verified rows first

Certaracertara.comin𝕏NASDAQ: CERTApr 2026SEC filingmedium confidence

Certara provides biosimulation software, modeling, and regulatory services that support drug discovery and development across discovery, preclinical, clinical, regulatory, and market access phases.

AI & Machine LearningBiotechHealthtechSaaSRadnor, US

Daniel Corcoran(SVP and General Counsel)inWilliam Feehery(CEO and Director)inJieun W. Choe(Chief Strategy & Marketing Officer)inRichard M. Traynor(Senior Vice President and General Counsel)inCraig R. Rayner(President, Integrated Drug Development)Justin Edge(President, Regulatory and Access)in

Board seatJohn Reynders· per SEC Form D · filed Apr 2026

Co-investorsArsenal

Aerskaaerska.cominFeb 2026 · $39M

Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.

BiotechDeep TechHealthtechMedical Devices

Stuart Milstein(Chief Platform Officer, Co-founder)inJack O’Meara(Chief Executive Officer, Co-founder)inDave Hardwicke(Director, Head of Business Development, Co-founder)

Co-investorsage1BackedBlueYard CapitalEntrepreneur FirstGlobal Health Investment CorporationLingotto+6 more

Axonis Therapeuticsaxonis.usinOct 2024

Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.

BiotechDeep TechBoston, US

Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in

BoardCorey . Goodman(Director)inJonathan Leff(Director)in

Co-investorsSofinnova VenturesvenBio PartnersMRL Ventures FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+8 more

Beacon Biosciencesbeacon.bio

Beacon Biosignals develops AI-powered EEG analytics technology to improve diagnosis and treatment of neurological, psychiatric, and sleep disorders.

AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US

Jacob A. Donoghue, M.D., Ph.D.(Executive Officer, Director)Jacob Donoghue(CEO & Co-Founder)inJarrett Revels(CTO & Co-Founder)in

BoardCaitlin Donovan(Director)Pavel Raifeld(Director)Naveen Rao(Director)in

Co-investorsGeneral CatalystAlumni VenturesCatalio Capital Management, LPGV (Google Ventures)Irregular ExpressionsKicker Ventures+4 more

Cadence Neurosciencecadenceneuro.comin

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsJAZZ Venture PartnersLumira VenturesAngelini VenturesF-Prime CapitalMayo Clinic Ventures

Catenacatena-nano.comin

The page is a blog post offering beginner tips for planning a first concrete pour, covering site preparation, forming, finishing, and curing.

Construction Tech

Co-investorsElevate VenturesQED Investorsa16z cryptoAcrew CapitalBreyer CapitalGeneral Catalyst+6 more

Catena Biosciencescatenabio.cominSeed · Mar 2023 · $5M

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Marco Lobba(Founder)inMatthew Francis(Founder)inGeo Guillen

Co-investorsCalifornia Innovation FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)FREEFLOWGaingelsJude Gomila+14 more

Celericelerihealth.com

Celéri builds real-world evidence infrastructure that connects point-of-care outcomes, commercial registries, and regulatory-grade data for medtech and pharma sponsors, interventional pain physicians, and payers.

Digital HealthHealthtechMedical Devices

Co-investorsTwelve Below

Clexbioclexbio.comNov 2022 · $1M
Deep 6 AIdeep6.aiinSeries B · Jun 2022 · $30M

Data & InfrastructureHealthtechPasadena, US

Wout Brusselaers(Founder)inSondra Pepe(Executive Officer)inChristian Duvall(Executive Officer)inAntonia Holway(Executive Officer)inDoug Cassidy(Executive Officer)inPeter Casasanto(Executive Officer)in

Co-investorsInformed Ventures Advisors, LlcMemorialCare Innovation FundPoint72 VenturesTechstarsTMC Venture FundGSR Ventures

Epiwatchepiwatch.comin

EpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers.

Digital HealthHealthtechMedical DevicesBaltimore, US

Nathan Crone(Executive Officer, Director, Promoter)Gregory Krauss(Executive Officer, Director, Promoter)Teresa Prego(Executive Officer, Director)inDean Papadopoulos(Executive Officer, Director, Promoter)

BoardDaniel Hanley(Director)Richard Schmitt(Director)

Co-investorsMaryland TEDCOTEDCO

Hexelonhexel.comDefunct

A platform that enables communities to launch their own cryptocurrencies.

ConsumerCrypto & Web3Travel & HospitalityNew York City, US

John Palmer(CEO)inMarcus Molchany(CTO)

Co-investorsBlock54 CapitalValor Equity PartnersY CombinatorInvesto CapitalPolychain CapitalVentureSouq

Inflection Medicineinflectionmedicine.com

Inflection Medicine offers a genomic medicine platform that integrates into the EHR to manage genomic sequencing and unify genomic, clinical, and family data into a single continuously updated patient view.

BiotechDigital HealthHealthtech

Mensura Healthmensurahealth.com

Mensura Health is developing an electrochemical point-of-care diagnostic system that uses DNA aptamer-based sensors and disposable microfluidic cartridges to rapidly measure blood levels of anti-seizure medications in epilepsy patients.

BiotechDigital HealthMedical DevicesWeston, US

Steven Schachter(Founder & Head Scientific Advisor)inNancy Hsiung(Founder & Chief Operating Officer)Charles Keough(Founder & Chief Executive Officer)Valentin Gribkoff(Executive Officer, Director)

BoardRobert Smith(Independent Director, Chairman of the Board)

Neumirna Therapeuticsneumirna.com

Neumirna develops miRNA-based therapies for neurological diseases such as epilepsy and Parkinson's.

BiotechLongevity

Co-investorsInvivo Capital PartnersSunstone Capital

Neurauraneuraura.comin𝕏

Neuraura Biotech develops proprietary 3D micro-electrode and microsensor technology for high-fidelity neural recording and percutaneous stimulation, used to improve diagnostic and therapeutic solutions for neurological, psychiatric and sensory conditions.

BiotechFemTechHealthtechMedical DevicesCalgary, CA

Claire Dixon(CEO and Co-Founder)inPierre Wijdenes(CPO and Co-Founder)in

Co-investorsStartup TNTBoxOne Ventures

Neurona Therapeuticsneuronatherapeutics.cominJul 2024 · $120M

Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.

BiotechDeep TechHealthtechSouth San Francisco, US

Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)inCatherine Priest(Chief Development Officer)inGautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)

Co-investorsBerkeley FrontierThe Column GroupViking GlobalYsios CapitalAlexandriaFidelity Investments+8 more

Pragma Biopragmabio.com

Computational microbiome analysis platform for immunologic disorders

Kareem Barghouti(Founder)inMohamed Donia(Founder)in

Co-investors3CC | Third Culture CapitalGood AI CapitalHarmonix FundJoyance PartnersMerck Global Health Innovation FundMSD Global Health Innovation Fund+5 more

Prudentia Sciencesprudentiasciences.comin𝕏

Prudentia Sciences provides information and evaluation services for biotech and pharmaceutical companies to help investors and acquirers assess breakthrough therapies before due diligence begins.

AI & Machine LearningBiotechEnterprise SoftwareHealthtech

Sadiqa Mahmood(CEO & Founder)in

Co-investorsGeneral AtlanticMcKesson VenturesVirtue Ventures

Ryghtryght.aiinSeed · Aug 2023 · $4.3M

Ryght AI provides an artificial intelligence-powered platform that uses digital twin technology to help clinical research organizations and sponsors identify and select optimal sites for clinical trials.

AI & Machine LearningBiotechHealthtechMedical Devices

Dr. Chadi Nabhan(Chief Medical Officer)Tom Pike(President and Chief Executive Officer)

Co-investorsAIX VenturesFoothill VenturesPage One VenturesVirtue VenturesLDV PartnersTop Harvest Capital

Scaffoldscaffoldtx.com

Scaffold Therapeutics is a biotech company developing oral small-molecule therapies that restore normal activity of the TDP-43 protein to treat ALS and other TDP-43-driven neurodegenerative diseases.

BiotechDeep TechHealthtech

Statcounterstatcounter.comin𝕏

Statcounter provides website analytics and visitor tracking software that displays traffic data, user behavior, and engagement metrics in a simple interface.

AdTechData & InfrastructureMarketing TechSaaS

Aodhán Cullen(Founder and CEO)

Co-investorsGabriel Venture PartnersHomegrown CapitalHuangpu River CapitalKumpulan Modal PerdanaNucleation CapitalNventure+2 more

Tuva Healthtuvahealth.comin

Tuva provides infrastructure and data standardization solutions for healthcare analytics teams, enabling them to transform raw healthcare data into analysis-ready datasets.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSSalt Lake City, US

Aaron Neiderhiser(Founder)inCoco Zuloaga(Founder)inAaron Neiderhiser Coco Zuloaga(Founder)

Co-investorsBoxGroupEnsemble LabsVirtue VenturesY Combinator

Zafrenszafrens.cominDec 2021

Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.

AI & Machine LearningBiotechDeep TechSan Diego, US

Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin

BoardJustin Briggsin

Co-investorsAcequia Capital (AceCap)BlueYard CapitalFoundersX VenturesGlobal BrainHAWKTAILimec.xpand+3 more

Zenith Healthzenithhealth.ioPre-Seed · Aug 2024

Zenith was a women's health company offering an app and an AI assistant called Penny to support women through pregnancy with information and guidance.

Digital HealthFemTechHealthtech

Zetozeto-inc.comin𝕏

Zeto develops improved electroencephalography technology for diagnosing epilepsy and other neurological conditions.

Cloud ComputingDeep TechDigital HealthHealthtechMedical DevicesSan Francisco, US

Aswin Gunasekar(Founder and CEO)in

Co-investorsAphelion CapitalFoothill VenturesSVE Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Sea PharmaceuticalsAurelisBeacon BiosignalsHexokine TherapeuticsScaffold TherapeuticsSoovu

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.